These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 18071898)

  • 21. Treatment approaches for dual diagnosis clients in England.
    Schulte SJ; Meier PS; Stirling J; Berry M
    Drug Alcohol Rev; 2008 Nov; 27(6):650-8. PubMed ID: 18830860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Background and overview of mental health and substance abuse treatment systems: meeting the needs of women who are pregnant or parenting.
    Grella CE
    J Psychoactive Drugs; 1996; 28(4):319-43. PubMed ID: 9017555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Supporting good practice in the provision of services to people with comorbid mental health and alcohol and other drug problems in Australia: describing key elements of good service models.
    Merkes M; Lewis V; Canaway R
    BMC Health Serv Res; 2010 Dec; 10():325. PubMed ID: 21126376
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recommendations for Integrated Systems and Services for People With Co-occurring Mental Health and Substance Use Conditions.
    Minkoff K; Covell NH
    Psychiatr Serv; 2022 Jun; 73(6):686-689. PubMed ID: 34644127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems.
    McGovern MP; Lambert-Harris C; Gotham HJ; Claus RE; Xie H
    Adm Policy Ment Health; 2014 Mar; 41(2):205-14. PubMed ID: 23183873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated versus non-integrated management and care for clients with co-occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials.
    Donald M; Dower J; Kavanagh D
    Soc Sci Med; 2005 Mar; 60(6):1371-83. PubMed ID: 15626531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Substance abuse counselor and client reports of mental health screening and enhanced practices.
    Hurtado SL; Crain JA; Simon-Arndt CM; Highfill-McRoy RM
    Mil Med; 2012 Sep; 177(9):1049-57. PubMed ID: 23025134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical characteristics and service utilization patterns of clients with schizophrenia-spectrum disorders in public residential detoxification settings.
    Alvidrez J; Havassy BE
    Community Ment Health J; 2006 Apr; 42(2):131-42. PubMed ID: 16425102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental health indicator interaction in predicting substance abuse treatment outcomes in nevada.
    Greenfield L; Wolf-Branigin M
    Am J Drug Alcohol Abuse; 2009; 35(5):350-7. PubMed ID: 20180663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental health facilities with ketamine infusion therapy in the United States in 2020: Co-location of dual diagnosis mental health and substance use disorder treatment.
    Ware OD
    Exp Clin Psychopharmacol; 2024 Jun; 32(3):263-269. PubMed ID: 37917509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Counselor training in several evidence-based psychosocial addiction treatments in private US substance abuse treatment centers.
    Olmstead TA; Abraham AJ; Martino S; Roman PM
    Drug Alcohol Depend; 2012 Jan; 120(1-3):149-54. PubMed ID: 21831536
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-occurring disorders in the adolescent mental health and substance abuse treatment systems.
    Turner WC; Muck RD; Muck RJ; Stephens RL; Sukumar B
    J Psychoactive Drugs; 2004 Dec; 36(4):455-62. PubMed ID: 15751483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment concerns of women with co-occurring serious mental illness and substance abuse disorders.
    Penn PE; Brooks AJ; Worsham BD
    J Psychoactive Drugs; 2002; 34(4):355-62. PubMed ID: 12562103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Utilization and outcomes of mental health services among patients in drug treatment.
    Hser YI; Grella C; Evans E; Huang YC
    J Addict Dis; 2006; 25(1):73-85. PubMed ID: 16597575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Which substance abuse treatment facilities offer dual diagnosis programs?
    Mojtabai R
    Am J Drug Alcohol Abuse; 2004 Aug; 30(3):525-36. PubMed ID: 15540491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implementing dual diagnosis services for clients with severe mental illness.
    Drake RE; Essock SM; Shaner A; Carey KB; Minkoff K; Kola L; Lynde D; Osher FC; Clark RE; Rickards L
    Psychiatr Serv; 2001 Apr; 52(4):469-76. PubMed ID: 11274491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the co-occurring capability of mental health treatment programs: the Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) Index.
    Gotham HJ; Brown JL; Comaty JE; McGovern MP; Claus RE
    J Behav Health Serv Res; 2013 Apr; 40(2):234-41. PubMed ID: 23334656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Job frustration in substance abuse counselors working with offenders in prisons versus community settings.
    Perkins EB; Oser CB
    Int J Offender Ther Comp Criminol; 2014 Jun; 58(6):718-34. PubMed ID: 23525175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical needs of in-treatment pregnant women with co-occurring disorders: implications for primary care.
    Lee King PA; Duan L; Amaro H
    Matern Child Health J; 2015 Jan; 19(1):180-7. PubMed ID: 24770992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.
    Mangrum LF; Spence RT; Lopez M
    J Subst Abuse Treat; 2006 Jan; 30(1):79-84. PubMed ID: 16377455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.